If the companies' exclusivities which are still in the pipeline like Diovan and Valcyte are from this plant then there can be significant financial impact, says Sriram Rathi.
first published: Sep 16, 2013 09:41 am
A collection of the most-viewed Moneycontrol videos.

Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell

Live: Will Nifty's weakness continue for the second straight day? | Opening Bell

A money superpower you have in your 20s, not in 40s

Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
You are already a Moneycontrol Pro user.

